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T he regulation of subcutaneous adipose tissue blood flow (ATBF) is crucial in lipid homeostasis (1, 2) . It has long been recognized that ATBF is tightly regulated (3) . A major role for the sympathetic innervation of adipose tissue in regulation of ATBF has long been established (3) (4) (5) (6) . In response to feeding, an increase in ATBF is seen in healthy subjects (3) . Glucosedependent insulinotropic polypeptide (GIP) is involved in the increase of ATBF in healthy subjects (7) (8) (9) . GIP is a polypeptide hormone secreted from the small-intestinal K cells in response to nutrient intake (10) . GIP is well founded as an incretin hormone potentiating insulin release from b-cells in healthy humans (10) (11) (12) . In addition to its insulinotropic effects, we have previously shown that GIP infusion during physiologic hyperinsulinemia and hyperglycemia increases ATBF and stimulates glucose uptake and triacylglycerol (TAG) deposition in adipose tissue in lean humans (7) . In contrast, in these experiments neither GIP nor hyperinsulinemia per se had any effect W i t h d r a w n on ATBF. Subsequent studies in lean healthy subjects demonstrated that insulin is essential for GIP to increase ATBF and adipose tissue TAG clearance (9) . In obese humans with impaired glucose tolerance, GIP infusion in combination with hyperinsulinemia and hyperglycemia did not induce any changes in ATBF and TAG uptake in adipose tissue (13) . However, weight loss (mean weight loss, 7.5 kg) induced by caloric restriction in obese humans with impaired glucose tolerance resulted in improved insulin sensitivity and partly restored the vasodilatory effect of GIP and insulin during otherwise comparable experimental conditions (8) . Recently, we demonstrated that the circulatory and metabolic effects of GIP in adipose tissue can be blocked by a truncated form of human GIP, GIP(3-30)NH2, which is a high-affinity competitive antagonist of the human GIP receptor (14) . In addition, we have previously shown that in abdominal subcutaneous adipose tissue of healthy lean subjects, there is an increased capillary recruitment in response to an oral glucose load, as indicated by an increased microvascular volume (15) . The recruitment of capillaries exposes a larger amount of the circulating TAG particles to the endothelial lipoprotein lipase (LPL), increasing the hydrolysis of these particles. This, in turn, gives rise to increased free fatty uptake in adipose tissue. Thus, the aim of this study was to elucidate whether the effects of GIP on ATBF and lipid metabolism involve capillary recruitment in healthy lean subjects.
Design, Methods, and Materials

Subjects
Eight healthy nonsmoking men were studied. The anthropometric characteristics, subcutaneous adipose tissue thickness, body fat composition, and lipid and glucose profiles are summarized in Table 1 . None of them used medication or had a positive family history of diabetes. All volunteers had normal plasma values of fasting glucose and hemoglobin and a normal lipid profile and renal and hepatic function. All subjects gave informed written consent to participate. The protocol was approved by the ethical committee of Copenhagen Municipality (H-15013961), and the study was performed in accordance with the Helsinki Declaration II.
Experimental design
The study protocol had a crossover design with a washout period of $2 weeks. Each subject served as his own control and was studied, in a randomized order, on two different occasions during infusion of GIP (1.5 pmol/kg per minute) or saline for 60 minutes, both days in combination with physiologic hyperglycemic-hyperinsulinemic (Hy gluc -Hy ins ) clamps, raising plasma glucose and insulin to postprandial levels.
Protocol
The subjects were instructed to abstain from drinking alcohol or doing strenuous physical activities for 2 days before the experiments to ensure equally filled glycogen stores. On the days of the experiments, subjects arrived at the department at 8:00 AM having used nonstrenuous transportation and after having fasted for $12 hours. The investigations were performed with the subjects in supine position in a room kept at 24°C. A catheter (BD Venflon, TMPRO; Becton Dickinson, Singapore) was inserted into an antecubital vein for the infusion of GIP, saline, glucose, insulin, and SonoVue (see below).
Another catheter was inserted percutaneously into the radial artery of the nondominant arm under local analgesia (1 mL 1% lidocaine) with an Artflon (Ohmeda, Swindon, UK) for blood sampling. The catheter was kept patent with regular flushing with saline.
After baseline measurements (time 230, 215, and 0 minutes) a continuous infusion of either GIP or saline in combination with the clamp was commenced.
GIP infusions and the clamp
GIP
Synthetic human GIP(1-42) was purchased from Bachem (Bubendorf, Switzerland) and demonstrated to be .97% pure and identical to the natural human peptide by HPLC mass spectrometry and sequence analysis. GIP was dissolved in saline containing 0.5% human serum albumin (Human Albumin; CSL Behring, Marburg, Germany) and subjected to sterile filtration.
Hy gluc -Hy ins clamp
The objective of the Hy gluc -Hy ins clamp was to increase plasma glucose levels above fasting levels (to 6.5 to 7 mM) and to increase insulin concentration to normal postprandial levels. The protocol included a continuous, variable glucose infusion. The infusion rate was adjusted every 5 to 10 minutes according to measured plasma glucose to maintain the glucose concentration at the desired target. Furthermore, during saline infusion, insulin (Actrapid Human; Novo Nordisk, Copenhagen, Denmark) was infused at a continuous rate of 10 mU/m 2 per minute. During concomitant GIP infusion, the insulin infusion rate was adjusted according to the expected endogenous insulin 
Contrast-enhanced ultrasound imaging and image analysis
Contrast-enhanced ultrasound imaging has previously been validated in our laboratory and is a reliable method to estimate the microvascular blood volume in human subcutaneous abdominal adipose tissue (15) . An ultrasound transducer was placed horizontally and each time at the same side of the abdomen~5 cm above the iliac crest in the midaxial line. The location of the transducer was highlighted before the infusions were started; thus it was possible to use the same location later (1 hour after the start of infusions). The transducer was held in a fixed position, and the subjects were instructed not to change body position during the measurements. At baseline and 1 hour after GIP or saline infusion, a bolus of 2.5 mL of the ultrasound contrast agent (SonoVue; Bracco Imaging S.p.A., Milan, Italy) was injected intravenously, followed by an immediate flush of 10 mL 0.9% saline solution. SonoVue is a suspension of phospholipid-stabilized microbubbles filled with hexafluoride; it is diluted with 4.5 mL 0.9% saline solution before injection (8 mL microbubbles per milliliter). Ultrasound scanning was performed with a linear array transducer (L9-3 MHz) and an iU22 ultrasound scanner (Phillips Medical Systems, Bothell, WA). B-mode imaging is created from broadband spectra of acoustic frequencies from 3 to 9 MHz. Contrast first harmonic signals were received at 8 MHz, with a mechanical index of 0.06. The depth was set at 3 cm, allowing measurements in abdominal subcutaneous adipose tissue. Focus and gain were optimized at the beginning of the experiment and held constant throughout. Twentymillisecond images were captured consecutively for 2 minutes after each bolus injection.
Image analysis was performed offline with ultrasound quantification and analysis software (QLAB version 7; Phillips Medical Systems). The analysis consisted of examination of the region of interest (ROI) for each recording in the subcutaneous abdominal adipose tissue. The ROI placements were in areas that excluded larger vessels during the enhancement phase. In an ROI, the relative microvascular blood volume (expressed in DdB) in the tissue was determined as the mean signal intensity in decibels during the first plateau phase after subtraction of the mean signal intensity registered immediately before the contrast bolus injection ( Fig. 1) (16) .
Determination of ATBF
ATBF in the subcutaneous adipose tissue contralateral to the ultrasound transducer position was determined throughout the experiment by recording washout of 133 Xe, which was injected in gaseous form into the adipose tissue. This technique has previously been validated in our laboratory (17) . About 1 MBq gaseous 133 Xe mixed in about 0.1 mL of atmospheric air was injected into the periumbilical area of the subcutaneous adipose tissue. The washout rate of 133 Xe was measured continuously by a scintillation counting device placed over the exact site of injection and taped firmly in place (Mediscint; Oakfield Instruments, Oxford, UK). The ATBF was calculated from the mean washout rate constant determined in 30-minute periods corresponding to the time points when blood samples were drawn. A tissue/blood partition coefficient for 133 Xe of 10 mL/g was used. To detect early flow changes, a monoexponential curve was fitted to the washout curve registered in the basal control period immediately before the hormone infusions were initiated. The commencement of the vascular effects was defined when the slope of the 133 Xe washout curve deviated from the baseline slope by visual inspection.
Blood samples
Blood samples were drawn at time 230, 215, 0, and thereafter every 30 minutes until discontinuation of the infusion. Plasma glucose concentrations were measured every 5 to 10 minutes for clamp adjustments. Blood samples were collected from the artery for measurements of GIP, insulin, and C-peptide. Blood samples were collected into iced chilled tubes (Vacuetta; Greiner Labortechnic, Kremsmünster, Austria). Tubes for total GIP contained EDTA, and tubes for insulin contained heparin. All samples were centrifuged within 15 minutes for 15 minutes at 5000 g at 4°C and stored at 280°C until analysis.
Blood analysis
Total GIP was measured with a C-terminally directed antibody (code no. 80867), which reacts fully with intact GIP and N-terminally truncated forms as described in Lindgren et al. (18) . The standard was human GIP (catalog no. H-5645; Bachem), and the tracer was 125 I-labeled human GIP (catalog no. Nex402; PerkinElmer, Waltham, MA).
Plasma insulin and C-peptide concentrations were measured by auto-DELPHIA automatic fluoroimmunoassay (Wallac, Inc., Turku, Finland).
Plasma glucose was measured at bedside during the clamp experiments with the Radiometer ABL 725 blood gas analyzer (Radiometer Corp., Brønshøj, Denmark).
Calculations and statistical analysis
The ATBF (adipose tissue perfusion coefficient) was calculated from the mean washout rate constant determined in 30-minute periods corresponding to the time points when blood samples were drawn. ATBF was then calculated according to the equation ATBF = 2k 3 l 3 100, where k is the xenon Figure 1 . A curve from the subcutaneous abdominal adipose tissue after administration of a bolus of the ultrasound agent SonoVue in one subject. The first-phase plateau level is used to calculate the microvascular blood volume.
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washout constant and l is the tissue/blood partition coefficient (l) for 133 Xe. Sample size was determined before the study via power analysis (P = 0.8, a = 0.05) with regard to ATBF response based on our previous publications. Assuming an ATBF response as found previously in normal weight, healthy subjects, fewer than six subjects were needed in the current study.
All results are presented as mean 6 SEM. The significance of changes in ATBF with time was evaluated via two-way ANOVA for repeated measures. Changes in ultrasound signal intensity from baseline during GIP and saline infusions were compared via paired t test (two-tailed).
The Spearman correlation test was used to calculate the correlation between ATBF and microvascular volume.
Regulation of free fatty acid (FFA) release from the adipose tissue depends on coordinated activities in hormone-sensitive lipase (HSL) and LPL (1). The relative rates of action of HSL and LPL can be calculated as described in (19 Data were analyzed in GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA). P , 0.05 was considered statistically significant.
Results
Arterial hormone, glucose, and metabolite concentrations The clamps were carried out successfully. Plasma glucose levels reached the target levels of 6.8 6 0.1 and 6.9 6 0.1 mM 30 minutes after start of the infusion of GIP and saline, respectively ( Fig. 2A) . There was no significant difference between the amounts of glucose infused during these two experiments (27 6 5 and 17 6 3 g, P = 0.2), reflecting similar insulin levels during the two experiments. Plasma insulin levels increased significantly and reached levels of 359 6 8 and 308 6 3 pM 30 minutes after the start of infusion of GIP and saline, respectively (Fig. 2B) .
During GIP infusion, total plasma GIP concentrations increased significantly from fasting levels (8.3 6 0.8 mM) and after~30 minutes reached mean plateau levels of 115 6 9 pM, whereas plasma GIP levels remained unchanged during saline infusion (10.3 6 0.6 mM) (Fig. 2C) .
The arterial concentrations of the metabolites are given in Fig. 3 . Arterial TAG concentrations were similar during the two experiments and exhibited a slight decrease toward the end of the study (Fig. 3A) . Arterial FFA and glycerol concentrations decreased significantly (P = 0.02), with no differences seen between the two experiments ( Fig. 3B and 3C ). Figure 4 shows the abdominal subcutaneous ATBF during the two experiments. Baseline ATBF did not differ between the two studies (2.6 6 0.6 and 2.5 6 0.5 mL/min 
Changes in subcutaneous abdominal ATBF
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per 100 g tissue). During GIP infusion ATBF increased fourfold (11.4 6 1.9 mL/min per 100 g tissue, P = 0.004), whereas ATBF remained unchanged during saline infusion (2.7 6 1.9 mL/min per 100 g tissue).
Changes in net fluxes of TAG, FFA, glycerol, and glucose and the action of the enzymes LPL and HSL Figure 5 shows average net fluxes of TAG, FFA, glycerol, and glucose in adipose tissue at baseline and during GIP infusion. TAG clearance (P = 0.004, Fig. 5A ) increased, and FFA output (P = 0.006, Fig. 5B ) and glycerol output (P = 0.04, Fig. 5C ) decreased significantly during GIP infusion compared with saline. Likewise, there was a significant increase in glucose uptake during GIP infusion (P = 0.03, Fig. 5D ). In addition, a decreased FFA/glycerol output ratio was seen during GIP infusion (P = 0.05, Fig. 5E ).
At baseline (fasting state) the activity of HSL was high, resulting in the release of 296 nmol glycerol/ 100 g per minute, and concomitantly there was net outward flux of FFA and a reesterification fraction of only 12%. During GIP infusion, the activity of HSL was virtually zero, along with a fourfold increase in LPL activity to 158 nmol/100 g per minute. There was an increase in in situ reesterification fraction to 94%, indicating that the major proportion of LPLderived FFA is directed into the adipose tissue for storage.
Changes in microvascular blood volume
During the two experiments, baseline DdB signal intensities were almost similar (2.1 6 0.3 and 1.5 6 0.3 dB, respectively, P not significant; Fig. 6A and 6B ). After 1 hour GIP infusion, the DdB signal intensity increased significantly (3.6 6 0.4 dB Fig. 6A , P = 0.003) whereas no change was seen in the saline study (1.6 6 0.2 dB, Fig. 6B ).
There was a significant correlation between microvascular blood flow and ATBF during GIP (r = 0.85 and P = 0.01). No correlation was seen during saline infusion (r = 0.34 and P = 0.5).
Discussion
ATBF has a fundamental role in the regulation of the adipose tissue metabolism (3) . We have previously shown in several studies that infusing GIP in combination with insulin increases ATBF up to fivefold (7, 9, 14) . In line with these findings we now show that the increase in ATBF with postprandial plasma levels of GIP and insulin involves capillary recruitment. Capillary recruitment has long been recognized in the skeletal muscle (20) (21) (22) . Few studies have suggested that adipose tissue possesses the ability of capillary recruitment (15, 23) . However, in the postprandial period adipose tissue metabolism depends, at least in part, on 
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increases in the macrovascular and microvascular perfusion rates (24) . The increase in blood flow in adipose tissue after feeding parallels that of plasma GIP and insulin concentrations (25) . Several mechanisms influence the regulation of postprandial ATBF in humans (24) . In humans, adrenergic mechanisms are dominant, with b 1 -receptor-mediated vasodilatation (4, 6) and a 2 -receptor-mediated vasoconstriction being the main regulators (26) . The blood flow response to feeding is blocked by propranolol infusion (completely in some adipose tissue depots and partially in others) (6), suggesting that it is dependent on sympathetic activation. The mechanisms behind the induction of the capillary recruitment in the adipose tissues are yet unknown, but a study from our laboratory showed that infusion of adrenaline increased both ATBF and capillary recruitment (27) .
Insulin per se has been suggested to induce vasodilatation in skeletal muscle. Baron (28) was the first to propose that the ability of insulin to increase limb and muscle blood flow might be a critical part of its delivery and thus its ability to stimulate glucose uptake. Although this proposal has been supported by a number of studies in both normal-weight and obese or insulin-resistant subjects (29) (30) (31) , other studies have failed to show an insulin-induced increase in blood flow, especially at physiologic levels of insulin (32, 33) . These conflicting results have led to some disagreement in the field as to whether insulin can increase skeletal muscle blood flow at physiologic levels. On the other hand, it has been shown in rats that insulin can mediate capillary recruitment within skeletal muscle and that it can be blocked by systemic administration of the nitric oxide synthase inhibitor. 
The same pathway may also be relevant for GIP's action in the adipose tissue microvasculature, because the GIP-induced vasodilatory actions appear to be mediated via endothelium-dependent nitric oxide production (34) . In the current study, hyperinsulinemia per se did not have any effect on ATBF or adipose tissue microvascular volume. These findings are in accordance with our previous studies, in which we found that neither insulin nor GIP per se has any effect on ATBF but that GIP in the presence of insulin above a certain concentration increases ATBF and adipose tissue TAG deposition (7) . Administration of even larger amounts of insulin did not elicit further increase in ATBF, indicating that insulin plays a permissive but not additive role for the vasodilatory effect of GIP (9) . This effect of GIP is probably receptor mediated because it can be abolished when the human GIP receptor is antagonized (14) . GIP receptors are found also in human adipose tissue (35) , and recent studies indicate that GIP receptor expression in subcutaneous adipose tissue is inversely associated with body mass index (36, 37) .
Interestingly, the other incretin hormone, glucagonlike peptide 1 (GLP-1), also increases total blood flow in adipose tissue in healthy subjects, but with a delay compared with the effect of GIP (38) . Furthermore, GLP-1 is shown to increase microvascular recruitment in human and rat muscle (39) . Whether GLP-1 also increases microvascular recruitment in adipose tissue remains to be elucidated.
In the postprandial state, the adipose tissue's metabolic role is primarily to deposit circulating triglycerides (1) . As the enzyme LPL is bound to the adipose tissue capillaries, the capillary recruitment (i.e., enlarged vascular surface area in the adipose tissue) will increase exposure of the circulating lipoproteins to the enzyme and lead to a postprandial increase in lipid deposition in the adipose tissue, at least in healthy subjects (1) . Coupled with our previous findings (7, 9, 14) , where we found an increase in TAG hydrolysis, FFA re-esterification, and glucose uptake, this finding is consistent with a coordinated GIP response in adipose tissue resulting in increased TAG deposition in abdominal subcutaneous adipose tissue via the conversion of glucose to a-glycerol-phosphate to esterify the FFAs derived from the TAG hydrolysis.
In conclusion, subcutaneous adipose tissue capillaries are recruited simultaneously with increased ATBF in response to GIP with insulin in healthy lean subjects, thus increasing the exposure of LPL to its substrate.
